JOHNSON JOHN (CIK 1410781) reported 16 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-23). Recent activity: Buy AXGN (14,150 shares), Sell XERS (15,000 shares), Buy XERS (24,193 shares), Buy AXGN (11,050 shares), Sell AXGN (11,050 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Axogen, Inc. (AXGN) | Director | Buy | 14,150 | $0 |
| 2026-06-05 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Sell | 15,000 | $91,422 |
| 2026-06-05 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Buy | 24,193 | $0 |
| 2026-05-08 | Axogen, Inc. (AXGN) | Director | Buy | 11,050 | $77,792 |
| 2026-05-08 | Axogen, Inc. (AXGN) | Director | Sell | 11,050 | $477,968 |
| 2025-12-19 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Sell | 135,400 | $977,588 |
| 2025-12-10 | Axogen, Inc. (AXGN) | Director | Sell | 11,802 | $368,931 |
| 2025-12-10 | Axogen, Inc. (AXGN) | Director | Buy | 11,891 | $74,913 |
| 2025-12-10 | Axogen, Inc. (AXGN) | Director | Sell | 11,891 | $371,237 |
| 2025-12-10 | Axogen, Inc. (AXGN) | Director | Buy | 8,545 | $53,834 |
| 2025-12-10 | Axogen, Inc. (AXGN) | Director | Sell | 8,545 | $256,179 |
| 2025-12-10 | Axogen, Inc. (AXGN) | Director | Sell | 13,141 | $393,967 |
| 2025-08-15 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Sell | 107,500 | $786,900 |
| 2025-06-11 | Axogen, Inc. (AXGN) | Director | Sell | 4,073 | $43,215 |
| 2025-06-04 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Buy | 50,000 | $0 |
| 2025-05-27 | Verastem, Inc. (VSTM) | Director | Buy | 8,333 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23